Filing Details
- Accession Number:
- 0001628280-24-028993
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-18 21:45:33
- Reporting Period:
- 2024-06-17
- Accepted Time:
- 2024-06-18 21:45:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1771910 | Adc Therapeutics Sa | ADCT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1656998 | Robert Azelby | 430 Mountain Avenue, Suite 404 New Providence NJ 07974 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Disposition | 2024-06-17 | 6,995 | $2.89 | 53,005 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents Common Shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units.
Billionaire Hedge Funds
